Check out market updates

Arca Biopharma slates third quarter for COVID treatment trial results

WESTMINSTER — ARCA Biopharma Inc. (Nasdaq: ARCA) posted far higher expenses in 2020 as it pivoted to COVID-19 treatment research, […]
Source: BizWest

Leave a Reply

Your email address will not be published. Required fields are marked *